by Kate Pym | Sep 10, 2026 | Blog, Business, Business development, Commercial, Consultancy, Healthcare, None
I recently came across a piece of research that made me think again about something we talk about frequently in healthcare: data. Not simply how much data we collect, but whether we are collecting the right information, connecting it appropriately and, importantly,...
by Kate Pym | Jun 15, 2026 | Blog, Business, Business development, Commercial, Consultancy
One of the realities of running a business is that not every part of the job plays to your strengths or interests. At heart, I am a salesperson. Not in the stereotypical sense of persuading people to buy things they do not need, but in helping people understand how a...
by Kate Pym | Feb 24, 2026 | Blog, Business, Commercial, Consultancy, Financial
There are moments in consultancy that make you stop and reflect, not because something went wrong in a dramatic sense, but because it highlights a structural issue that rarely gets discussed openly. Some time ago, I was contacted by a Scottish university and invited...
by Kate Pym | Jul 8, 2025 | Blog, Business, Business development, Commercial, Healthcare
The newly published Defining the Size of the Health Innovation Prize report by Frontier Economics, commissioned by the Health Innovation Network, highlights a transformative opportunity for the UK. It sets out a bold, evidence-based case for strategic investment in...
by Kate Pym | Jun 12, 2025 | Blog, Business, Commercial, Healthcare, Press Release
The OrQA-UK trial, a major research study aiming to reduce the number of donated organs that go unused, has been awarded funding by the National Institute for Health and Care Research (NIHR). The OrQA tool uses Artificial Intelligence (AI) to help assess donor livers,...
by Kate Pym | Mar 12, 2025 | Blog, Business, Consultancy, NHS
Recent findings from a comprehensive review at Walsall Healthcare NHS Trust have cast a stark light on the consequences of clinical errors in medical practice. The report unveiled that 24% of the 382 cases reviewed were associated with moderate to severe harm to...
